Literature DB >> 28676944

[Network disorders in neurology].

J Claßen1, D Saur2, G R Fink3,4.   

Abstract

Mesh：

Year:  2017        PMID： 28676944     DOI： 10.1007/s00115-017-0372-5

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  8 in total

1.  Millisecond-timescale, genetically targeted optical control of neural activity.

Authors:  Edward S Boyden; Feng Zhang; Ernst Bamberg; Georg Nagel; Karl Deisseroth
Journal:  Nat Neurosci       Date:  2005-08-14       Impact factor: 24.884

2.  A Spotlight on Bridging Microscale and Macroscale Human Brain Architecture.

Authors:  Martijn P van den Heuvel; B T Thomas Yeo
Journal:  Neuron       Date:  2017-03-22       Impact factor: 17.173

3.  Striatal activation by optogenetics induces dyskinesias in the 6-hydroxydopamine rat model of Parkinson disease.

Authors:  Ledia F Hernández; Ivan Castela; Irene Ruiz-DeDiego; Jose A Obeso; Rosario Moratalla
Journal:  Mov Disord       Date:  2017-03-03       Impact factor: 10.338

4.  Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice.

Authors:  Xiomara A Perez; Danhui Zhang; Tanuja Bordia; Maryka Quik
Journal:  Mov Disord       Date:  2017-03-03       Impact factor: 10.338

Review 5.  Targeting Neural Circuits.

Authors:  Priyamvada Rajasethupathy; Emily Ferenczi; Karl Deisseroth
Journal:  Cell       Date:  2016-04-21       Impact factor: 41.582

6.  Optical deconstruction of parkinsonian neural circuitry.

Authors:  Viviana Gradinaru; Murtaza Mogri; Kimberly R Thompson; Jaimie M Henderson; Karl Deisseroth
Journal:  Science       Date:  2009-03-19       Impact factor: 47.728

Review 7.  Integration of optogenetics with complementary methodologies in systems neuroscience.

Authors:  Christina K Kim; Avishek Adhikari; Karl Deisseroth
Journal:  Nat Rev Neurosci       Date:  2017-03-17       Impact factor: 34.870

8.  Transcranial magnetic stimulation of dorsolateral prefrontal cortex reduces cocaine use: A pilot study.

Authors:  Alberto Terraneo; Lorenzo Leggio; Marina Saladini; Mario Ermani; Antonello Bonci; Luigi Gallimberti
Journal:  Eur Neuropsychopharmacol       Date:  2015-12-04       Impact factor: 5.415
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.